Animal Physiology Laboratory, Faculty of Biology, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Master Program in Biotechnology, Postgraduate School, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Int Microbiol. 2022 Aug;25(3):531-540. doi: 10.1007/s10123-022-00239-8. Epub 2022 Feb 14.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new virus responsible for the COVID-19 pandemic. The emergence of the new SARS-CoV-2 has been attributed to the possibility of evolutionary dynamics in the furin cleavage site (FCS) region. This study aimed to analyze the sequence of the FCS region in the spike protein of SARS-CoV-2 isolates that circulated in the Special Region of Yogyakarta and Central Java provinces in Indonesia. The RNA solution extracted from nasopharyngeal swab samples of confirmed COVID-19 patients were used and subjected to cDNA synthesis, PCR amplification, sequencing, and analysis of the FCS region. The sequence data from GISAID were also retrieved for further genome analysis. This study included 52 FCS region sequences. Several mutations were identified in the FCS region, i.e., D614G, Q675H, Q677H, S680P, and silent mutation in 235.57 C > T. The most important mutation in the FCS region is D614G. This finding indicated the G614 variant was circulating from May 2020 in those two provinces. Eventually, the G614 variant totally replaced the D614 variant from September 2020. All Indonesian SARS-CoV-2 isolates during this study and those deposited in GISAID showed the formation of five clade clusters from the FCS region, in which the D614 variant is in one specific cluster, and the G614 variant is dispersed into four clusters. The data indicated there is evolutionary advantage of the D614G mutation in the FCS region of the spike protein of SARS-CoV-2 circulating in the Special Region of Yogyakarta and Central Java provinces in Indonesia.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是一种新病毒,引发了 COVID-19 大流行。新出现的 SARS-CoV-2 可能与该病毒在弗林蛋白酶裂解位点(FCS)区域的进化动态有关。本研究旨在分析在印度尼西亚日惹特区和中爪哇省流行的 SARS-CoV-2 分离株刺突蛋白中 FCS 区域的序列。从确诊 COVID-19 患者的鼻咽拭子样本中提取 RNA 溶液,进行 cDNA 合成、PCR 扩增、测序,并对 FCS 区域进行分析。还从 GISAID 检索序列数据进行进一步的基因组分析。本研究共纳入 52 条 FCS 序列。在 FCS 区域发现了几个突变,包括 D614G、Q675H、Q677H、S680P 和 235.57C>T 的沉默突变。FCS 区域最重要的突变是 D614G。这一发现表明,G614 变体自 2020 年 5 月起在这两个省流行。最终,G614 变体从 2020 年 9 月开始完全取代了 D614 变体。本研究期间所有印度尼西亚 SARS-CoV-2 分离株以及在 GISAID 中保存的分离株均显示出 FCS 区域形成了五个聚类簇,其中 D614 变体位于一个特定的聚类簇中,而 G614 变体则分散在四个聚类簇中。数据表明,在印度尼西亚日惹特区和中爪哇省流行的 SARS-CoV-2 刺突蛋白的 FCS 区域中,D614G 突变具有进化优势。